Fact CheckerSign in

NCT06596317Completed

Impact of Indigo Carmine Pump Spraying on the Adenoma Detection Rate

Impact of Indigo Carmine Pump Spraying on the Adenoma Detection Rate: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 12 Mar 2025

Brief summary (registry, in English)

Detection and removal of polyps during colonoscopy is crucial for the prevention of colorectal cancer. Indigo carmine spraying up to the colonic mucosa could probably increase the adenoma detection rate. The traditional method of dye spraying with spraying catheter or syringe would consume a lot of time and dye volume. Now, the more convenient auxiliary water supply channel can be used to spray indigo carmine. In order to explore the clinical application value of spraying indigo carmine solution by auxiliary water channel in high-risk population, we performed a prospective, randomized controlled trial to compare adenoma detection rate of conventional colonoscopy and chromoendoscopy.

Status (registry)
Completed
Study type
Interventional
Enrollment
330 (actual)
First submitted
12 Apr 2023
Start date
11 Jan 2024
Primary completion date
30 Dec 2024
Lead sponsor
Shandong University
NCT number
NCT06596317

What you commit to

  • Study type: Interventional
  • Participants enrolled: 330
  • From 11 Jan 2024 to the primary completion date, 30 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who received urgent or therapeutic colonoscopy
  • Patients with aspirin, clopidogrel or other anticoagulants/ antiplatelet drugs intake within 7 days

Other illness

  • Patients with pregnancy, inflammatory bowel disease, polyposis syndromes, suspected CRC; intestinal obstruction, coagulopathy

Other

  • Patients with severe comorbidity
  • Patients who are not suitable for colonoscopy
  • Patients with failed cecal intubation
  • Patients with inadequate bowel preparation quality (Boston score ≤5)
  • Patients who refuse to participate or to provide informed consent

Who the study is looking for

  • Patients with a history of colorectal cancer or colorectal adenoma
  • Patients whose first-degree relatives have a history of colorectal cancer or colorectal adenoma
  • Patients with gastrointestinal symptoms (abdominal pain, bloody stool, chronic diarrhea or constipation, Unexplained anemia or weight loss;
  • Patients with positive fecal occult blood tests

Age in the registry: 45 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Qilu Hospital of Shandong University
Coordinator of this site? Confirm its status
JinanChinaUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.